Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Thiotepa, Busulfan, and Cyclophosphamide and Busulfan, Cyclophosphamide, Etoposide As Autologous Stem Cell Transplantation Conditioning Regimen in Primary Central Nervous System Lymphoma

Jaewon Hyung, MD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Kyoungmin Lee, MD, Shin Kim, RN, Chan-Sik Park, Jooryung Huh, MD PhD, Jin-Sook Ryu, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 3300.

https://doi.org/10.1182/blood.V130.Suppl_1.3300.3300

Published: 2017

Journal Articles

Salvage Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Jaewon Hyung, MD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Kyoungmin Lee, MD, Shin Kim, RN, Chan-Sik Park, Jooryung Huh, MD PhD, Jin-Sook Ryu, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 5506.

https://doi.org/10.1182/blood.V130.Suppl_1.5506.5506

Published: 2017

Journal Articles

Adding Beta-2 Microglobulin for Better Prognostication of Primary Central Nervous System Lymphoma

Jaewon Hyung, MD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Kyoungmin Lee, MD, Shin Kim, RN, Chan-Sik Park, Jooryung Huh, MD PhD, Jin-Sook Ryu, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 4139.

https://doi.org/10.1182/blood.V130.Suppl_1.4139.4139

Published: 2017

Journal Articles

The Absolute Lymphocyte Count Is Associated with the Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified

Byeong Seok Sohn, MDPhD, Jeongseok Kim, MD, Dok Hyun Yoon, MD PhD, Shin Kim, RN, Jooryung Huh, MD PhD, Sung-En Park, MD, Young Jin Yuh, MD PhD, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 2803.

https://doi.org/10.1182/blood.V130.Suppl_1.2803.2803

Published: 2017

Journal Articles

The Efficacy of Systemic High Dose Methotrexate As Central Nervous System Prophylaxis in Patients with High Risk Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Analysis

Kyoungmin Lee, MD, Dok Hyun Yoon, MD PhD, Jung Yong Hong, Jung Bok Lee, PhD, Shin Kim, RN, Jung Sun Park, MSc, Jooryung Huh, MD PhD, Sang Wook Lee, MD, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 4130.

https://doi.org/10.1182/blood.V130.Suppl_1.4130.4130

Published: 2017

Journal Articles

Prognostic Impact Of Beta-2 Microglobulin In Patients With Non-Gastric Marginal Zone Lymphoma

Changhoon Yoo, M.D, Dok Hyun Yoon, MD, Shin Kim, RN, Jooryung Huh, MD, Chan-Jeoung Park, MD, Sang-wook Lee, MD, Cheolwon Suh

Blood (2013) 122 (21): 4297.

https://doi.org/10.1182/blood.V122.21.4297.4297

Published: 2013

Journal Articles

Efficacy and Safety of Reduced Dose Intensity R-CHOP in Elderly Patients with Diffuse Large B Cell Lymphoma

Jungmin Jo, MD, Dok Hyun Yoon, MD, Sang-wook Lee, MD, Chan-Sik Park, MD, Jooryung Huh, MD, Kyoungmin Lee, RN, Eun Hee Kang, RN, Shin Kim, RN, Cheolwon Suh, MD

Blood (2012) 120 (21): 3674.

https://doi.org/10.1182/blood.V120.21.3674.3674

Published: 2012

Journal Articles

Peripheral Blood Hematopoietic Progenitor Cell (HPC) Counts At Autologous Stem Cell Collection (ASCC) Are Associated with Prognosis in Multiple Myeloma

Yoon Ji Choi, MD, Dok Hyun Yoon, MD, Jungmin Jo, MD, Kyoungmin Lee, RN, Eun Hee Kang, RN, Shin Kim, RN, Seongsoo Jang, MD, Chan Jeoung Park, Hyun Sook Chi, Cheolwon Suh, MD

Blood (2012) 120 (21): 4412.

https://doi.org/10.1182/blood.V120.21.4412.4412

Published: 2012

Journal Articles

Prognostic Value of Positron Emission Tomography- Computed Tomography in Patients with Marginal Zone Lymphoma

Ji Hyun Park, MD, Dok Hyun Yoon, MD, Sun Mok Kim, Jae-Cheol Jo, Jeongseok Kim, MD, Shin Kim, RN, Kyoungmin Lee, RN, Eun Hee Kang, RN, Sang-wook Lee, MD, Chan-Sik Park, MD, Jooryung Huh, Cheolwon Suh, MD

Blood (2012) 120 (21): 5084.

https://doi.org/10.1182/blood.V120.21.5084.5084

Published: 2012

Journal Articles

Clinicopathologic Characteristics and Clinical Outcomes in Patients with Testicular Non-Hodgkin Lymphoma

Jeongseok Kim, MD, Dok Hyun Yoon, MD, Ji Hyun Park, MD, Il Young Jang, MD, Shin Kim, RN, Kyoungmin Lee, RN, Eun Hee Kang, RN, Jooryung Huh, MD, Chan-Sik Park, MD, Cheolwon Suh, MD

Blood (2012) 120 (21): 5111.

https://doi.org/10.1182/blood.V120.21.5111.5111

Published: 2012

Journal Articles

Comparison Between CD20-Negative and CD20-Positive Diffuse Large B Cell Lymphoma; Characteristics and Clinical Outcome

Jungmin Jo, M.D, Changhoon Yoo, M.D, Yongchel Ahn, MD, Seong Joon Park, M.D, Shin Kim, RN, Dae Ho Lee, MD, Sang We Kim, MD, Jungsin Lee, MD, Cheolwon Suh, MD

Blood (2010) 116 (21): 4891.

https://doi.org/10.1182/blood.V116.21.4891.4891

Published: 2010

Journal Articles

Comparison of Survival and Clinical Features In Different Age Cohorts of Patients with Multiple Myeloma: A Single Center Experience

Jae Ho Jeong, MD, Shinkyo Yoon, MD, Dalyong Kim, MD, Jeong Eun Kim, MD, Dok Hyun Yoon, MD, Shin Kim, RN, Cheolwon Suh, MD

Blood (2010) 116 (21): 4997.

https://doi.org/10.1182/blood.V116.21.4997.4997

Published: 2010

Journal Articles

PROGNOSTIC SIGNIFICANCE of CD68 EXPRESSION for Korean PATIENTS with HODGKIN'S LYMPHOMA

Dok Hyun Yoon, MD, Young Wha Koh, MD, Shin Kim, RN, Chan-Sik Park, Dae Ho Lee, Sang-We Kim, Sang-wook Lee, Cheolwon Suh, MD, Jooryung Huh, MD

Blood (2010) 116 (21): 3888.

https://doi.org/10.1182/blood.V116.21.3888.3888

Published: 2010

Journal Articles

Poor Survival of IgD Multiple Myeloma Following High-Dose Melphalan and Autologous Stem Cell Transplantation.

Yong Pil Jeong, MD, Shin Kim, RN, Ock Bae Ko, MD, Ja Eun Koo, MD, Danbi Lee, MD, Cheolwon Suh, MD

Blood (2005) 106 (11): 5161.

https://doi.org/10.1182/blood.V106.11.5161.5161

Published: 2005

Journal Articles

BEAC or BEAM Chemotherapy Followed by Autologous Stem Cell Transplantation in Non-Hodgkin’s Lymphoma Patients: Comparative Analysis on Efficacy and Toxicity.

Ja Eun Koo, MD, Shin Kim, RN, Ock Bae Ko, MD, Danbi Lee, MD, Young Pill Chong, MD, Yoon-Koo Kang, MD, Jooryung Huh, MD, Cheolwon Suh, MD

Blood (2005) 106 (11): 5291.

https://doi.org/10.1182/blood.V106.11.5291.5291

Published: 2005

Journal Articles

Beneficial Prophylactic Antimicrobial Use Against Infectious Complications during Autologous Stem Cell Transplantation: A Result of Randomized Phase II Study in Multiple Myeloma and Non-Hodgkin’s Lymphoma Patients.

Shin Kim, RN, Yang Hee Cho, RN, Ock Bae Ko, MD, Ja Eun Koo, MD, Danbi Lee, MD, Young Pill Chong, MD, Cheolwon Suh, MD

Blood (2005) 106 (11): 5477.

https://doi.org/10.1182/blood.V106.11.5477.5477

Published: 2005

Journal Articles

Burkitt’s Lymphoma in Korea: Clinical Manifestations and Efficacy of Modified CALGB 9251 Regimen (BNHL).

Danbi Lee, MD, Shin Kim, RN, Ock Bae Ko, MD, Ja Eun Koo, MD, Young Pill Chong, MD, Jooryung Huh, MD, Cheolwon Suh, MD

Blood (2005) 106 (11): 4661.

https://doi.org/10.1182/blood.V106.11.4661.4661

Published: 2005

NARROW

Thiotepa, Busulfan, and Cyclophosphamide and Busulfan, Cyclophosphamide, Etoposide As Autologous Stem Cell Transplantation Conditioning Regimen in Primary Central Nervous System Lymphoma

Salvage Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Adding Beta-2 Microglobulin for Better Prognostication of Primary Central Nervous System Lymphoma

The Absolute Lymphocyte Count Is Associated with the Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified

The Efficacy of Systemic High Dose Methotrexate As Central Nervous System Prophylaxis in Patients with High Risk Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Analysis

Prognostic Impact Of Beta-2 Microglobulin In Patients With Non-Gastric Marginal Zone Lymphoma

Efficacy and Safety of Reduced Dose Intensity R-CHOP in Elderly Patients with Diffuse Large B Cell Lymphoma

Peripheral Blood Hematopoietic Progenitor Cell (HPC) Counts At Autologous Stem Cell Collection (ASCC) Are Associated with Prognosis in Multiple Myeloma

Prognostic Value of Positron Emission Tomography- Computed Tomography in Patients with Marginal Zone Lymphoma

Clinicopathologic Characteristics and Clinical Outcomes in Patients with Testicular Non-Hodgkin Lymphoma

Comparison Between CD20-Negative and CD20-Positive Diffuse Large B Cell Lymphoma; Characteristics and Clinical Outcome

Comparison of Survival and Clinical Features In Different Age Cohorts of Patients with Multiple Myeloma: A Single Center Experience

PROGNOSTIC SIGNIFICANCE of CD68 EXPRESSION for Korean PATIENTS with HODGKIN'S LYMPHOMA

Poor Survival of IgD Multiple Myeloma Following High-Dose Melphalan and Autologous Stem Cell Transplantation.

BEAC or BEAM Chemotherapy Followed by Autologous Stem Cell Transplantation in Non-Hodgkin’s Lymphoma Patients: Comparative Analysis on Efficacy and Toxicity.

Beneficial Prophylactic Antimicrobial Use Against Infectious Complications during Autologous Stem Cell Transplantation: A Result of Randomized Phase II Study in Multiple Myeloma and Non-Hodgkin’s Lymphoma Patients.

Burkitt’s Lymphoma in Korea: Clinical Manifestations and Efficacy of Modified CALGB 9251 Regimen (BNHL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only